Skip to main content
letter
. 2021 Apr 15;203(8):1037–1041. doi: 10.1164/rccm.202011-4161LE

Table 1.

In Vivo Phenotype Analysis of ∆proABC/piaA and ∆fhs/piaA Mutant Strains in Mouse Infection Models

Infection Conditions and Model Target Organ and (if Applicable) Group 6B Wild Type
∆proABC/piaA
∆fhs/piaA
PBS Control Mice
Log10 cfu/ml n Log10 cfu/ml n Log10 cfu/ml n Log10 cfu/ml n
Virulence models                  
 Pneumonia Lungs 5.26 (0.55) 5 3.78 (1.50)* 5 4.54 (0.35) 5 N/A
Blood 3.30 (0.77) 5 0 (0) 5 0 (0) 5 N/A
 Colonization Nasal wash 4.13 (0.41) 10 3.99 (0.05) 5 3.55 (0.46) 5 N/A
Colonization-then-challenge models                  
 6B pneumonia Lungs 3.70 (1.86) 15 2.51 (2.03) 16 2.40 (3.24) 11 3.66 (2.68) 16
Blood 0 (0)§ 15 0 (0)§ 16 0 (0)§ 11 2.09 (3.89) 16
BALF 2.00 (2.18) 15 2.00 (2.38) 16 0 (1.09)* 11 2.83 (1.20) 16
 6B pneumonia in μMT mice Lungs, wild-type control mice 4.54 (0.86) 6 4.10 (0.50) 6 3.11 (1.46) 6 N/A
Lungs, μMT mice 4.08 (0.32) 3 4.18 (0.88) 6 4.28 (0.39) 6 N/A
Blood, wild-type control mice 0 (0) 6 0 (0) 6 0 (0) 6 N/A
Blood, μMT mice 3.54 (0.77) 3 0 (2.48) 6 3.23 (0.43)* 6 N/A
 6B pneumonia in CD4+ cell–depleted mice Lungs, untreated control mice 3.27 (2.91) 6 3.59 (2.89) 6 3.24 (2.73) 6 N/A
Lungs, CD4+ cell–depleted mice 3.54 (2.19) 5 1.33 (2.88) 6 3.47 (1.40) 6 N/A
Blood, untreated control mice 0 (0) 6 0 (0) 6 0 (0) 6 N/A
Blood, CD4+ cell–depleted mice 0 (0) 5 0 (0) 6 0 (0) 6 N/A
 6B colonization Nasal wash 2.71 (1.46) 10 1.54 (1.81)§ 10 2.54 (0.94)* 10 3.88 (0.16) 10
 TIGR4 colonization Nasal wash, untreated control mice 1.00 (1.78)* 5 1.98 (2.99) 6 1.75 (1.66) 6 3.84 (0.47) 6
Nasal wash, CD4+ cell–depleted mice 2.52 (0.92) 6 2.90 (1.03) 6 3.38 (0.40) 6 3.36 (0.73) 6

Definition of abbreviations: BALF = BAL fluid; N/A = not applicable; PBS = phosphate-buffered saline; S. pneumoniae = Streptococcus pneumoniae.

For the pneumonia model, colony-forming units were obtained 28 hours after intranasal inoculation with 1 × 107 S. pneumoniae CFU in 50 μl PBS under deep isoflurane anesthesia, and for the colonization model, 7 days after colonization with 1 × 107 cfu in 10 μl PBS under light isoflurane anesthesia (4, 6, 8). For colonization-then-challenge experiments, mice underwent two episodes of colonization (Days 0 and 14) with 1 × 107 cfu in 10 μl PBS under light isoflurane anesthesia of wild-type BHN418 6B, ∆proABC/piaA, or ∆fhs/piaA S. pneumoniae strains or sham colonization with PBS before challenge between Days 30 and 42. For these, the data presented are pooled from two experiments except the colonization-with-∆proABC/piaA-and-then-challenge experiment, which includes pooled data from three experiments. The μMT−/− mice were in the C57B/6J background (kind gift from Claudia Mauri, University College London); all other experiments used CD1 mice aged 4–8 weeks. CD4+ cells were depleted by intraperitoneal injection of 250 μg anti-CD4 mAb (GK 1.5; BioxCell) 48 and 24 hours before S. pneumoniae challenge (6); flow cytometry confirmed >99% depletion of splenic CD4+ cells (data not shown). Data are presented as the median of log10 cfu/ml (interquartile range) recovered from target organs after infection with wild-type, ∆proABC/piaA, ∆fhs/piaA, or PBS control mice. P values were obtained using Kruskal-Wallis tests with Dunn’s post hoc test comparing groups with the wild-type 6B strain (for virulence models) or the PBS sham-colonized group (for colonization-then-challenge data). The Mann-Whitney test was used for experiments with μMT−/− mice and CD4+ cell–depleted mice, comparing wild-type/untreated mouse data with μMT−/−/CD4+ cell–depleted mouse data, respectively, for each target organ and S. pneumoniae strain combination.

*

P < 0.01.

P < 0.05.

Combined data from two repeated experiments.

§

P < 0.001.